Key facts
- It has raised $2.5M; the latest was Seed Round ($2.5M) in May 2025.
- Notable investors include Vento, B Heroes, 2100 Ventures, Exceptional Ventures, Italian Founders Fund — 13 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for ReportAId
- ·The full record, as it builds
Funding rounds
No funding rounds for ReportAId are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About ReportAId
Developer of a medical report interpretation platform designed to structure unstructured clinical data. The company's platform specializes in extracting insights from medical reports using artificial intelligence and offers patient relationship management (PRM) to facilitate the booking of patient follow-up appointments, enabling the healthcare industry to enhance patient care, automate follow-ups, and integrate report data into existing systems.
- Sector
- Healthcare
- HQ
- Milan, Italy
- Founded
- 2023
- Employees
- 8
- Website
- reportaid.ai/
- Ownership
- Privately Held (backing)
ReportAId doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ReportAId shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ReportAId in its N-PORT filings yet. We sweep new filings monthly.